For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

23rd Nov 09

FDA Advisory Committee Recommends Approval of Aridol

Pharmaxis today announced that an advisory committee of the U.S. Food and Drug Administration (FDA) has voted to recommend the approval of Aridolâ„¢ (mannitol bronchial challenge test) for use as a bronchial test to assess bronchial hyperresponsiveness to aid in diagnosing patients who have symptoms of asthma or symptoms that are suggestive of asthma.


Read full media release - pdf